A review of the management of MDR-TB in a resource-limited setting in India

A. Dalal, R. Desai (Mumbai, India)

Source: Annual Congress 2010 - Global tuberculosis control
Session: Global tuberculosis control
Session type: Thematic Poster Session
Number: 3155
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Dalal, R. Desai (Mumbai, India). A review of the management of MDR-TB in a resource-limited setting in India. Eur Respir J 2010; 36: Suppl. 54, 3155

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Poor treatment outcomes of XDR-TB patients in resource-limited settings
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012

MDR-TB guidelines: what is new on clinical management
Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management
Year: 2020


MDR-TB treatment in prison setting
Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector
Year: 2007


Out-patient MDR-TB care in Moldova
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

The health economics of treating MDR-TB in the Indian private sector
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016


National evidence on the inefficiency of an inpatient model of tuberculosis management in Eastern Europe
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013

Centralization of M/XDR-TB care in clinical reference centres in Portugal. Experience of a regional reference centre
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


Improvement of TB epidemiological situation in Tomsk Oblast within the MDR-TB treatment program
Source: Annual Congress 2008 - Asthma and miscellaneous disorders
Year: 2008

Management of severe COVID-19 in resource-poor settings
Source: Virtual Congress 2020 – Hot topics in intensive care: COVID-19: Lessons learned
Year: 2020


Outcomes of MDR-TB treatment in penitentiary medical setting
Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups
Year: 2008

Pragmatic tuberculosis prevention policies for primary care in low- and middle-income countries
Source: Eur Respir J, 51 (3) 1800315; 10.1183/13993003.00315-2018
Year: 2018



Changing prevalence of MDR TB and XDR TB in a tertiary care hospital in India
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


MDR-TB in Eastern Europe: new public health interventions
Source: International Congress 2016 – The problem of multidrug-resistant tuberculosis
Year: 2016


A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate?
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Cameroon's MDR-TB treatment programme jeopardised by cross-border migration
Source: Eur Respir J 2016; 47: 684-686
Year: 2016


All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings
Source: Eur Respir J, 59 (1) 2004345; 10.1183/13993003.04345-2020
Year: 2022



XDR-TB in South Africa: from clinical management to public-health action
Source: Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management
Year: 2011